Health
Arthritis drug Tocilizumab reduces severe Covid mortality: study – Bangkok Post
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts…
PARIS – The arthritis drug tocilizumab reduces the risk of critically ill patients dying of Covid-19, according to results of a study on Thursday which experts welcomed as an “exciting” development.
The Britain-based RECOVERY research programme investigating Covid-19 treatments said their findings could have a significant effect on hospital survival rates during the pandemic.
The study included more than 2,000 patients who received the drug intravenously compared with nearly 3,000 who were given…
-
Noosa News17 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General15 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News17 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Noosa News8 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050